Melanotan II is a research-grade melanocortin peptide supplied strictly for in-vitro and laboratory research use only. It is not for human or animal consumption, is not a cosmetic, is not a dietary supplement, and is not an FDA-approved drug. This profile is third-person science education describing what Melanotan II is and what researchers measure when they study it in cell-culture and animal-model systems. Nothing here is medical, dosing, or cosmetic guidance, and nothing implies any reader should acquire or use the compound.
What Melanotan II Is
Melanotan II is a synthetic, cyclic analog of the natural signaling peptide alpha-MSH, studied as a molecular tool in melanocortin receptor pharmacology. In the research literature it is the canonical example of how cyclization reshapes melanocortin chemistry, and it appears frequently as a reference agonist when investigators compare receptor responses. It is a research-use-only reference material, not a product intended for people or animals. For foundational background on peptide structure, see what peptides are.
The compound is characterized as a broad, potent agonist across several melanocortin receptor subtypes rather than a single-subtype-selective ligand. That breadth is exactly why it is so widely used in laboratory pharmacology: a broad reference agonist provides a common comparison point across the whole receptor family. Everything described here concerns receptor and cell biology in controlled research systems.
Melanotan II sits within the same sexual-health and melanocortin research category as related analogs, and the PT-141 profile covers a compound with a more central receptor emphasis. The product-level overview for this compound lives at the Melanotan 2 research reference. This profile focuses on Melanotan II as a named research chemical, describing its cyclic chemistry, the receptors it engages in cell studies, and the documentation that lets a laboratory trust the material.
Structure: A Cyclic Lactam Constraint
Structurally, Melanotan II incorporates a lactam ring that constrains the conserved melanocortin message segment, often summarized as His-Phe-Arg-Trp (the HFRW pharmacophore). This cyclization locks the active portion of the molecule into a conformation that both improves receptor engagement and resists rapid enzymatic breakdown. The literature describes Melanotan II as enzymatically stable as a direct result of this ring constraint.
This is the structural contrast that separates Melanotan II from the linear analog Melanotan I. Where the linear compound retains an open-chain backbone and leans toward MC1R activity, the cyclic architecture of Melanotan II is associated with broad, potent activity across multiple subtypes. The features investigators reference most often are:
- A cyclic lactam ring that constrains the HFRW message segment into a stable, active conformation.
- Enzymatic stability that follows from the cyclization, making the compound a reproducible reference agonist.
- Broad receptor activity across multiple melanocortin subtypes rather than single-subtype selectivity.
- A structural contrast to the linear, MC1R-leaning analog Melanotan I, illustrating how cyclization reshapes pharmacology.
Receptor Pharmacology: Broad Melanocortin Agonism
The melanocortin receptor family comprises five G-protein-coupled receptors, MC1R through MC5R, each coupling to the Gs pathway and driving accumulation of cyclic AMP (cAMP) when activated. In cloned-receptor panels, Melanotan II is reported to engage several of these subtypes, which is why it appears so frequently as a broad reference agonist in comparative studies. Investigators use it to benchmark subtype responses under standardized conditions.
MC1R is the subtype most associated with pigment-cell biology, and it is a common focus in studies that use Melanotan II in melanocyte cultures. The central subtypes MC3R and MC4R, tied in animal models to hypothalamic circuitry, are also part of the compound's broad profile. Because it activates the family broadly rather than selectively, Melanotan II is a useful tool for mapping the shared Gs-cAMP signaling readout across receptors. The receptor points most often referenced are:
- MC1R, associated with pigment-cell biology and frequently studied with Melanotan II in melanocyte cultures.
- MC3R and MC4R, the central subtypes tied in animal models to hypothalamic circuitry.
- MC5R, associated in the literature with exocrine-gland biology, included in subtype comparison panels.
- A shared Gs-cAMP readout across the family, which broad agonists like Melanotan II are well suited to probe.
Mechanisms Studied in Preclinical and In-Vitro Models
Research on Melanotan II spans the molecular level, where the compound is characterized at individual receptors, and the cellular and systems level, where pigment-cell cultures and animal models are examined. Both levels are strictly preclinical, and the compound functions as a probe for characterizing receptor and cell behavior in non-human systems.
Nothing in this literature describes an effect in a person, and observations in cell cultures or animal models do not transfer to humans. Melanotan II is referenced here only as a laboratory research material used to generate mechanistic data. Any question that touches human health belongs with a licensed clinician, not a research-chemical profile.
Pigment-Cell (Melanogenesis) Models
A large part of the Melanotan II literature uses melanocyte cell cultures, because MC1R signaling is central to the biology of pigment-producing cells. In these models, investigators expose cultured melanocytes to defined concentrations of the compound and measure markers of melanogenesis, the cellular process by which the pigment melanin is synthesized. Endpoints can include the activity of enzymes such as tyrosinase and the amount of pigment produced by the culture.
These are observations within specific melanocyte-culture systems and describe cellular behavior in a laboratory dish. They are not evidence of any cosmetic or physiological result in a person or animal. The pigment-cell model is simply one of the most informative systems for studying MC1R-linked signaling, which is why it recurs throughout melanocortin research.
Central Receptor Circuits
Beyond pigment biology, Melanotan II is used in receptor studies that touch the central subtypes MC3R and MC4R. In animal models these receptors sit within hypothalamic circuitry, and a broad agonist provides a way to probe how that circuitry responds relative to more selective ligands. The broader receptor map connecting these compounds is developed in the melanocortin system research guide.
As with the pigment-cell work, these are mechanistic observations in non-human systems. They characterize how a broad melanocortin agonist interacts with receptors and circuits under controlled laboratory conditions and carry no implication for use in humans or animals.
Handling, Solubility, and Stability
In research settings, Melanotan II is typically supplied as a lyophilized (freeze-dried) solid. Laboratory reconstitution generally uses a suitable sterile solvent, often bacteriostatic or sterile water, added slowly against the vial wall so the peptide dissolves gently. The concentration prepared depends on the design of a given experiment. These are standard peptide-handling notes for laboratory work only, not instructions for any use in people or animals.
Sealed lyophilized vials are usually stored frozen and protected from light and moisture, while reconstituted solutions are generally kept refrigerated and used within a limited window, with repeated freeze-thaw cycles avoided. Handling should follow supplier documentation and institutional practice. The cyclic lactam structure contributes to the compound's stability, but proper storage remains important for reproducible research results.
What Researchers Measure
When Melanotan II is used as a reference compound, the measurements investigators report cluster around receptor pharmacology, pigment-cell biology, and material quality. Typical endpoints include:
- Receptor binding affinity across the melanocortin subtypes in cloned-receptor systems.
- Functional potency, measured as cAMP accumulation reflecting Gs-coupled receptor activation.
- Melanogenesis markers such as tyrosinase activity and pigment output in melanocyte cultures.
- Peptide stability under defined storage and reconstitution conditions.
- Identity and purity of the supplied lot, confirmed by analytical testing before use in any experiment.
Why Purity and a Certificate of Analysis Matter
In peptide research, a measurement is only as reliable as the compound behind it. A cyclic peptide like Melanotan II can be confounded by truncated sequences, incomplete cyclization, or residual synthesis byproducts, any of which can distort receptor and pigment-cell data and make an experiment impossible to reproduce. Documenting exactly what a vial contains is a scientific requirement.
A Certificate of Analysis (COA) documents what analytical testing confirmed for a specific lot. A meaningful COA reports identity, typically by mass spectrometry, and purity, typically by high-performance liquid chromatography (HPLC) expressed as a main-peak percentage, and it ties those results to a lot number that matches the physical vial. Peptides Factory Direct documents identity and purity for its research-use-only catalog; to review procurement terms, see order.
- Identity confirmation by mass spectrometry, verifying the molecular weight matches the intended cyclic peptide.
- Purity by HPLC, reported as a main-peak percentage that flags truncation or byproducts.
- Lot-number traceability, linking the COA to the exact vial in hand.
- Documentation that lets one experiment be compared meaningfully against another.
Regulatory and Compliance Context
Stating the regulatory category plainly is part of responsible science communication. Melanotan II supplied here is a research chemical for laboratory and in-vitro use only. It is not a drug, is not a dietary supplement, is not a cosmetic, and is not approved by the FDA for the topics discussed. It is not for human or animal consumption and is not intended for application to or administration into the body in any form. The presence of pigment-related compounds in some consumer contexts does not change the intended use of this research-grade material.
Any question about skin health, pigmentation, sexual health, or other human-health topics belongs with a licensed clinician, never with a research-chemical purchase. Researchers handling Melanotan II are responsible for complying with the laws and institutional rules that apply in their jurisdiction. For the broader research category and related answer-first material, see sexual-health peptides and the research questions hub.
Create a free research account to view current pricing and bundles and place an order.
Frequently asked questions
What is Melanotan II in a research context?
Melanotan II is a synthetic, cyclic analog of alpha-MSH studied as a molecular tool in melanocortin receptor pharmacology. In laboratory work it serves as a broad reference agonist across melanocortin subtypes and is frequently used in melanocyte cell cultures to study MC1R-linked signaling. It is a research-use-only reference material, not a drug, supplement, or cosmetic, and it is not for human or animal consumption. It is studied to generate data, not outcomes in people.
Why is Melanotan II described as cyclic?
Melanotan II contains a lactam ring that constrains the conserved His-Phe-Arg-Trp message segment into a stable, active conformation. This cyclization improves receptor engagement and makes the compound enzymatically stable, which is why it is a reproducible reference agonist. The cyclic architecture is the structural contrast to the linear analog Melanotan I. This description concerns molecular chemistry in research contexts and says nothing about any use in humans or animals.
Which receptors does Melanotan II engage?
In cloned-receptor panels, Melanotan II is reported to engage several melanocortin subtypes rather than one selectively, which is why it is used as a broad reference agonist. The family has five subtypes, MC1R through MC5R, all coupling to Gs and driving cAMP accumulation. MC1R is central to pigment-cell studies, while MC3R and MC4R are central subtypes tied to hypothalamic circuitry in animal models. These are in-vitro pharmacology observations, not effects in people.
How does Melanotan II differ from Melanotan I and PT-141?
All three are melanocortin analogs studied only as research materials. Melanotan I is a linear compound described as MC1R-leaning. Melanotan II is a cyclic, enzymatically stable analog characterized as a broad, potent agonist across subtypes. PT-141 (bremelanotide) is discussed in connection with central signaling, with MC4R among its receptor interests. The differences are matters of structure and receptor emphasis in laboratory pharmacology, not claims about any effect in humans or animals.
What is melanogenesis in cell research?
Melanogenesis is the cellular process by which pigment-producing cells synthesize melanin. In melanocyte cell cultures, researchers study melanogenesis by measuring markers such as the activity of the enzyme tyrosinase and the amount of pigment a culture produces. Because MC1R signaling is central to this biology, melanocortin agonists like Melanotan II are common tools in these models. The observations describe cellular behavior in a dish, not any cosmetic or physiological result in a person or animal.
How is Melanotan II handled and stored in research?
In laboratory settings, lyophilized Melanotan II is typically reconstituted with a suitable sterile solvent, often bacteriostatic or sterile water, added slowly to the vial wall. Sealed vials are usually stored frozen and protected from light and moisture, while reconstituted solutions are kept refrigerated and used within a limited window, avoiding repeated freeze-thaw cycles. These are general research-handling notes for laboratory use only and are not instructions for any use in humans or animals.
Is Melanotan II FDA approved or for human use?
No. Melanotan II as supplied here is a research chemical for laboratory and in-vitro use only. It is not for human use, animal use, or any form of consumption, and it is not a food, drug, supplement, or cosmetic. It is not FDA approved for the research topics described. Any question about skin, pigmentation, or health belongs with a licensed clinician. Qualified researchers handling the material must follow all applicable laws and institutional rules.
Why do purity and a COA matter for Melanotan II?
Receptor and pigment-cell data are only as trustworthy as the compound behind them, and a cyclic peptide can be confounded by truncation, incomplete cyclization, or byproducts. A Certificate of Analysis documents identity by mass spectrometry and purity by HPLC, tied to a lot number that matches the physical vial. That chain of identity lets one experiment be compared meaningfully against another and attributes any finding to the intended molecule rather than an unverified impurity.
All guides · Order research peptides
External references: U.S. Food and Drug Administration · Peptide (Wikipedia)